| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |